Press Room

Search Search PressRoom
Click to Open Search
   
Sections
Home
Company Mission
Press Room
Scientific Advisory Board
Strategic Alliances
Significance of Body Composition Measurements

On-Site DEXA Measurements
Body Chemistry Testing
On-Going R&D
Database of Medical Bio Markers
 
 
First Quarter Net Profit
 
     
 
Published on August 22, 2006
 
     
 

SEC Form 10-Q for second quarter 2006 reports first quarterly net profit in Company’s history and implementation of cost-cutting measures including :

    • Executive positions of Director, CEO, President and CFO combined into single executive

                                    position without increases in compensation

    • No executive compensation paid since merger in June 2006
    • Executive compensation to be provided only for quarters in which the company is profitable
    • Strategic relationships established with healthcare and nutritional companies within the Company’s area of expertise reducing the need to compensate outside consultants
    • Cash flow increased by profit sharing with portfolio companies 
    • Efforts increased to recapture improperly issued shares
      • Potential dilution of share values by impending conversion of preferred stock into 8,000,000,000 common shares
    • Potential distraction from primary mission resulting from reorganization efforts